Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06232590 · ClinicalTrials.gov registry record · NA
Performance Comparison of Two Monthly Replacement Silicone Hydrogel Multifocal Lens Types
A NA study, sponsored by CooperVision International Limited (CVIL).
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT06232590 is a NA study that has completed, run by CooperVision International Limited (CVIL). The registered enrollment target is 60 participants.
The verdict
NCT06232590, a NA study, has completed, sponsored by CooperVision International Limited (CVIL).
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
To evaluate and compare the performance of two monthly replacement multifocal contact lenses in existing wearers.
Interventions
- DEVICE Control Lens (comfilcon A)
- DEVICE Test Lens (lehfilcon A)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2024-02-23 |
| Est. Completion | 2024-07-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06232590
The ClinicalTrials.gov registry entry for NCT06232590 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is CooperVision International Limited (CVIL), which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Control Lens (comfilcon A) is the first listed.
NCT06232590 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06232590 about?
NCT06232590 is a clinical study titled "Performance Comparison of Two Monthly Replacement Silicone Hydrogel Multifocal Lens Types". To evaluate and compare the performance of two monthly replacement multifocal contact lenses in existing wearers.
What is the current status of trial NCT06232590?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2024-02-23. Estimated completion is 2024-07-09.
What interventions are being tested in trial NCT06232590?
The interventions under investigation include: Control Lens (comfilcon A) (DEVICE), Test Lens (lehfilcon A) (DEVICE).
Who is sponsoring clinical trial NCT06232590?
This trial is sponsored by CooperVision International Limited (CVIL), which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.